Serum MLC concentrations in patients with active disease (median 31 ng/ml) were significantly greater than those in the patients with inactive disease (median 0-32 ng/ml) (p = 0 0002) (figure). In particular, all 17 measurements in patients exhibiting active disease were increased. Among these patients, serum MLC values were increased in three patients who were considered to have active disease (as defined above), despite normal CK concentrations; two of these three were not treated with corticosteroids and one was treated with prednisone 10 mg/day. In two patients, muscle biopsy confirmed an active inflammatory process. In nine patients with inactive disease, three of 10 measurements were elevated (>1 ng/ml). Further studies are needed to clarify the significance of these findings.
The relationship between serum MLC concentration and disease activity over time was examined in five patients. A marked reduction in serum MLC was noted when the disease became inactive (as defined above). In patients with active disease the median serum MLC concentration was 68-8 ng/ml, compared with 3-7 ng/ml in patients with inactive disease. In four patients, however, MLC values remained increased three months after normalisation of the CK concentration at a time when the patients were considered clinically to have inactive disease. Further studies involving serial muscle biopsies from patients in this group will clarify the significance of this finding.
Our preliminary data in patients with inflammatory myopathies demonstrate increased serum MLC concentrations which correlate strongly with disease activity. Our results suggest that measurement of MLC concentrations may be advantageous in diagnosis and the evaluation of response to treatment. In myositis the response to treatment is particularly difficult to monitor because of the rapid normalisation of the electromyogram and CK levels. Whether 8-2 (3.2)*t Values are mean (SD). Group I = primary hyperuricaemic; group 11 = primary hyperuricaemichyperlipidaemic. Significant differences: *p < 0-05, **p < 0-01, ***p < 0-001 for comparison of A with B; fP < 0-05, -fp < 0-01, tffp < 0-001 for comparison of group I with group II.
In order to investigate alterations in the renal excretion of uric acid in relation to plasma concentrations of triglycerides, we carried out a dietary intervention study in hyperuricaemic patients who were placed on a controlled low calorie regimen intended to decrease their triglyceride concentrations.
We studied 15 primary hyperuricaemic patients (all men) (group I) and 15 primary hyperuricaemic-hyperlipidaemic patients (all men) (group II). Subjects with plasma uric acid concentrations greater than 7 mg/dl were classed as hyperuricaemic, and those with values greater than 200 mg/dl,7 as hyperlipidaemic. All were subjected to an initial basal analytical determination for uric acid, total triglycerides, total cholesterol, and uric acid clearance and fractional excretion after three days on a low purine diet,8 followed by a second determination after three weeks on a low calorie diet (1200 kcal per day: carbohydrate = 50%; protein = 20%; lipid = 30%) with alcohol excluded. Three days after the second determination, patients were again placed on a low purine diet similar to that used before the first determination.
The Wilcoxon test was used to evaluate the significance of differences between the means in the two patient groups before and after low calorie dieting. Statistically significant difference between the two groups was calculated by the Mann-Whitney test.
The table shows the results. All the patients lost a significant amount of body weight on dieting, regardless of the group to which they belonged, but uric acid levels did not change in either group as a result of dieting.
Patients in group II (hyperuricaemichyperlipidaemic) exhibited considerably decreased triglyceride and cholesterol concentrations after the low calorie diets, concomitant with increased renal excretion of uric acid, which was not observed in group I.
Our results support the hypothesis that the association between triglyceride concentration and renal excretion of uric acid is more than a casual relationship; by decreasing triglyceride concentrations, we succeeded in increasing renal uric acid excretion without pharmacological intervention, while controlling the purine intake during assessment of the renal excretion of uric acid. In our opinion, the relationship is particularly valid in hyperuricaemic-hyperlipidaemic patients, as the decrease in the triglyceride concentrations and weights of the hyperuricaemicnormolipidaemic men (group I) was not accompanied by increased renal excretion of uric acid. Collantes et al6 also found that renal excretion of urate was less in hyperuricaemic-hyperlipidaemic patients than in hyperuricaemic-normolipidaemic patients. Acute increase in serum triglyceride concentrations has been shown not to modify uric acid synthesis or excretion.3 9 However, these data are not conclusive, as ingested triglycerides have a different composition and metabolic origin than endogenous triglycerides.
Other authors have shown an inverse correlation between insulin sensitivity and uric acid concentration,'0 and between insulin resistance and clearance of uric acid from healthy volunteers." The potential link between the inverse relationship of the renal excretion of uric acid with hyperinsulinism and our findings remains to be determined. The mechanisms responsible for such an inverse relationship between renal excretion of uric acid and triglyceride concentrations will probably be elucidated as knowledge of the metabolic syndrome expands. 
